Pharmacokinetics of Bispecific Antibody
Authors:
- 5 May 2017
- journal article
- research article
- Published by Springer Nature in Current Pharmacology Reports
- Vol. 3 (3) , 126-137
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- The making of bispecific antibodiesmAbs, 2016
- “NextGen” Biologics: Bispecific Antibodies and Emerging Clinical ResultsExpert Opinion on Biological Therapy, 2016
- Brain penetration, target engagement, and disposition of the blood‐brain barrier‐crossing bispecific antibody antagonist of metabotropic glutamate receptor type 1The FASEB Journal, 2016
- Alternative molecular formats and therapeutic applications for bispecific antibodiesMolecular Immunology, 2015
- Bispecific antibodiesDrug Discovery Today, 2015
- Therapeutic bispecific antibodies cross the blood-brain barrier in nonhuman primatesScience Translational Medicine, 2014
- Antitumor Efficacy of a Bispecific Antibody That Targets HER2 and Activates T CellsCancer Research, 2014
- Addressing Safety Liabilities of TfR Bispecific Antibodies That Cross the Blood-Brain BarrierScience Translational Medicine, 2013
- T cell-engaging BiTE antibodies specific for EGFR potently eliminate KRAS- and BRAF-mutated colorectal cancer cellsProceedings of the National Academy of Sciences, 2010
- Properties of the Major Component of a Peptic Digest of Rabbit AntibodyScience, 1960